Compuesto heterocíclico y uso del mismo
Se proporciona un compuesto heterocíclico que puede tener una acción antagonista sobre un receptor NMD A que contiene la subunidad NR2B y que se espera que sea útil como agente profiláctico o terapéutico para la depresión, el trastorno bipolar, la migraña, el dolor, los síntomas periféricos de la de...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | TOKUNAGA, Norihito WAKABAYSAHI, Takeshi TAKAKURA, Nobuyuki BANNO, Hiroshi KAMEI, Taku HIRAYAMA, Takaharu YONEMORI, Jinichi KAMATA, Makoto MATSUMOTO, Shigemitsu OGURO, Yuya KAMITANI, Hirotaka ITO, Mitsuhiro FUJIMOTO, Takuya TANAKA, Toshio IKEDA, Shuhei |
| description | Se proporciona un compuesto heterocíclico que puede tener una acción antagonista sobre un receptor NMD A que contiene la subunidad NR2B y que se espera que sea útil como agente profiláctico o terapéutico para la depresión, el trastorno bipolar, la migraña, el dolor, los síntomas periféricos de la demencia y similares. Un compuesto representado por la fórmula (I), en donde cada símbolo es como se define en la DESCRIPCIÓN, o una sal del mismo. (Traducción automática con Google Translate, sin valor legal)
Provided is a heterocyclic compound that can have an antagonistic action on an NMD A receptor containing the NR2B subunit and that is expected to be useful as a prophylactic or therapeutic agent for depression, bipolar disorder, migraine, pain, peripheral symptoms of dementia and the like. A compound represented by the formula (I), wherein each symbol is as defined in the DESCRIPTION, or a salt thereof. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ES2987270TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ES2987270TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ES2987270TT33</originalsourceid><addsrcrecordid>eNrjZNBwzs8tKE0tLslXyEgtSS3KTz68NjknMzlfoVKhtDhfISU1RyE3szg3n4eBNS0xpziVF0pzMyi6uYY4e-imFuTHpxYXJCan5qWWxLsGG1lamBuZG4SEGBsTowYAL5YphA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Compuesto heterocíclico y uso del mismo</title><source>esp@cenet</source><creator>TOKUNAGA, Norihito ; WAKABAYSAHI, Takeshi ; TAKAKURA, Nobuyuki ; BANNO, Hiroshi ; KAMEI, Taku ; HIRAYAMA, Takaharu ; YONEMORI, Jinichi ; KAMATA, Makoto ; MATSUMOTO, Shigemitsu ; OGURO, Yuya ; KAMITANI, Hirotaka ; ITO, Mitsuhiro ; FUJIMOTO, Takuya ; TANAKA, Toshio ; IKEDA, Shuhei</creator><creatorcontrib>TOKUNAGA, Norihito ; WAKABAYSAHI, Takeshi ; TAKAKURA, Nobuyuki ; BANNO, Hiroshi ; KAMEI, Taku ; HIRAYAMA, Takaharu ; YONEMORI, Jinichi ; KAMATA, Makoto ; MATSUMOTO, Shigemitsu ; OGURO, Yuya ; KAMITANI, Hirotaka ; ITO, Mitsuhiro ; FUJIMOTO, Takuya ; TANAKA, Toshio ; IKEDA, Shuhei</creatorcontrib><description>Se proporciona un compuesto heterocíclico que puede tener una acción antagonista sobre un receptor NMD A que contiene la subunidad NR2B y que se espera que sea útil como agente profiláctico o terapéutico para la depresión, el trastorno bipolar, la migraña, el dolor, los síntomas periféricos de la demencia y similares. Un compuesto representado por la fórmula (I), en donde cada símbolo es como se define en la DESCRIPCIÓN, o una sal del mismo. (Traducción automática con Google Translate, sin valor legal)
Provided is a heterocyclic compound that can have an antagonistic action on an NMD A receptor containing the NR2B subunit and that is expected to be useful as a prophylactic or therapeutic agent for depression, bipolar disorder, migraine, pain, peripheral symptoms of dementia and the like. A compound represented by the formula (I), wherein each symbol is as defined in the DESCRIPTION, or a salt thereof.</description><language>spa</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20241114&DB=EPODOC&CC=ES&NR=2987270T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20241114&DB=EPODOC&CC=ES&NR=2987270T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TOKUNAGA, Norihito</creatorcontrib><creatorcontrib>WAKABAYSAHI, Takeshi</creatorcontrib><creatorcontrib>TAKAKURA, Nobuyuki</creatorcontrib><creatorcontrib>BANNO, Hiroshi</creatorcontrib><creatorcontrib>KAMEI, Taku</creatorcontrib><creatorcontrib>HIRAYAMA, Takaharu</creatorcontrib><creatorcontrib>YONEMORI, Jinichi</creatorcontrib><creatorcontrib>KAMATA, Makoto</creatorcontrib><creatorcontrib>MATSUMOTO, Shigemitsu</creatorcontrib><creatorcontrib>OGURO, Yuya</creatorcontrib><creatorcontrib>KAMITANI, Hirotaka</creatorcontrib><creatorcontrib>ITO, Mitsuhiro</creatorcontrib><creatorcontrib>FUJIMOTO, Takuya</creatorcontrib><creatorcontrib>TANAKA, Toshio</creatorcontrib><creatorcontrib>IKEDA, Shuhei</creatorcontrib><title>Compuesto heterocíclico y uso del mismo</title><description>Se proporciona un compuesto heterocíclico que puede tener una acción antagonista sobre un receptor NMD A que contiene la subunidad NR2B y que se espera que sea útil como agente profiláctico o terapéutico para la depresión, el trastorno bipolar, la migraña, el dolor, los síntomas periféricos de la demencia y similares. Un compuesto representado por la fórmula (I), en donde cada símbolo es como se define en la DESCRIPCIÓN, o una sal del mismo. (Traducción automática con Google Translate, sin valor legal)
Provided is a heterocyclic compound that can have an antagonistic action on an NMD A receptor containing the NR2B subunit and that is expected to be useful as a prophylactic or therapeutic agent for depression, bipolar disorder, migraine, pain, peripheral symptoms of dementia and the like. A compound represented by the formula (I), wherein each symbol is as defined in the DESCRIPTION, or a salt thereof.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNBwzs8tKE0tLslXyEgtSS3KTz68NjknMzlfoVKhtDhfISU1RyE3szg3n4eBNS0xpziVF0pzMyi6uYY4e-imFuTHpxYXJCan5qWWxLsGG1lamBuZG4SEGBsTowYAL5YphA</recordid><startdate>20241114</startdate><enddate>20241114</enddate><creator>TOKUNAGA, Norihito</creator><creator>WAKABAYSAHI, Takeshi</creator><creator>TAKAKURA, Nobuyuki</creator><creator>BANNO, Hiroshi</creator><creator>KAMEI, Taku</creator><creator>HIRAYAMA, Takaharu</creator><creator>YONEMORI, Jinichi</creator><creator>KAMATA, Makoto</creator><creator>MATSUMOTO, Shigemitsu</creator><creator>OGURO, Yuya</creator><creator>KAMITANI, Hirotaka</creator><creator>ITO, Mitsuhiro</creator><creator>FUJIMOTO, Takuya</creator><creator>TANAKA, Toshio</creator><creator>IKEDA, Shuhei</creator><scope>EVB</scope></search><sort><creationdate>20241114</creationdate><title>Compuesto heterocíclico y uso del mismo</title><author>TOKUNAGA, Norihito ; WAKABAYSAHI, Takeshi ; TAKAKURA, Nobuyuki ; BANNO, Hiroshi ; KAMEI, Taku ; HIRAYAMA, Takaharu ; YONEMORI, Jinichi ; KAMATA, Makoto ; MATSUMOTO, Shigemitsu ; OGURO, Yuya ; KAMITANI, Hirotaka ; ITO, Mitsuhiro ; FUJIMOTO, Takuya ; TANAKA, Toshio ; IKEDA, Shuhei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ES2987270TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>TOKUNAGA, Norihito</creatorcontrib><creatorcontrib>WAKABAYSAHI, Takeshi</creatorcontrib><creatorcontrib>TAKAKURA, Nobuyuki</creatorcontrib><creatorcontrib>BANNO, Hiroshi</creatorcontrib><creatorcontrib>KAMEI, Taku</creatorcontrib><creatorcontrib>HIRAYAMA, Takaharu</creatorcontrib><creatorcontrib>YONEMORI, Jinichi</creatorcontrib><creatorcontrib>KAMATA, Makoto</creatorcontrib><creatorcontrib>MATSUMOTO, Shigemitsu</creatorcontrib><creatorcontrib>OGURO, Yuya</creatorcontrib><creatorcontrib>KAMITANI, Hirotaka</creatorcontrib><creatorcontrib>ITO, Mitsuhiro</creatorcontrib><creatorcontrib>FUJIMOTO, Takuya</creatorcontrib><creatorcontrib>TANAKA, Toshio</creatorcontrib><creatorcontrib>IKEDA, Shuhei</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TOKUNAGA, Norihito</au><au>WAKABAYSAHI, Takeshi</au><au>TAKAKURA, Nobuyuki</au><au>BANNO, Hiroshi</au><au>KAMEI, Taku</au><au>HIRAYAMA, Takaharu</au><au>YONEMORI, Jinichi</au><au>KAMATA, Makoto</au><au>MATSUMOTO, Shigemitsu</au><au>OGURO, Yuya</au><au>KAMITANI, Hirotaka</au><au>ITO, Mitsuhiro</au><au>FUJIMOTO, Takuya</au><au>TANAKA, Toshio</au><au>IKEDA, Shuhei</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Compuesto heterocíclico y uso del mismo</title><date>2024-11-14</date><risdate>2024</risdate><abstract>Se proporciona un compuesto heterocíclico que puede tener una acción antagonista sobre un receptor NMD A que contiene la subunidad NR2B y que se espera que sea útil como agente profiláctico o terapéutico para la depresión, el trastorno bipolar, la migraña, el dolor, los síntomas periféricos de la demencia y similares. Un compuesto representado por la fórmula (I), en donde cada símbolo es como se define en la DESCRIPCIÓN, o una sal del mismo. (Traducción automática con Google Translate, sin valor legal)
Provided is a heterocyclic compound that can have an antagonistic action on an NMD A receptor containing the NR2B subunit and that is expected to be useful as a prophylactic or therapeutic agent for depression, bipolar disorder, migraine, pain, peripheral symptoms of dementia and the like. A compound represented by the formula (I), wherein each symbol is as defined in the DESCRIPTION, or a salt thereof.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | spa |
| recordid | cdi_epo_espacenet_ES2987270TT3 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Compuesto heterocíclico y uso del mismo |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T17%3A56%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TOKUNAGA,%20Norihito&rft.date=2024-11-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EES2987270TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |